Impact of increasing post-filter ionized calcium target on filter lifespan in renal replacement therapy with regional citrate anticoagulation: A before-and-after study

被引:9
作者
Assefi, Mona [1 ,2 ]
Leurent, Alix [1 ,2 ]
Blanchard, Florian [1 ,2 ]
Quemeneur, Cyril [1 ,2 ]
Deransy, Romain [3 ]
Monsel, Antoine [1 ,2 ,4 ]
Constantin, Jean-Michel [1 ,2 ]
机构
[1] Sorbonne Univ, AP HP, GRC 29, 47-73 bd Hop, Paris, France
[2] Hop La Pitie Salpetriere, Dept Anaesthesiol & Crit Care, 47-73 bd Hop, Paris, France
[3] Univ Nantes, Serv Anesthesie Reanimat Chirurg, CHU Nantes, Pole Anesthesie Reanimat, Nantes, France
[4] Sorbonne Univ, INSERM UMRS 959, Immunol Immunopathol Immunotherapy I3, F-75013 Paris, France
关键词
Acute kidney injury; Continuous renal replacement therapy; Regional citrate anticoagulation; Ionized calcium; Intensive care; CONTINUOUS VENOVENOUS HEMODIALYSIS; CRITICALLY-ILL PATIENTS; HEPARIN ANTICOAGULATION; ACCUMULATION;
D O I
10.1016/j.jcrc.2023.154364
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Regional citrate anticoagulation (RCA) is the recommended method for anticoagulation in contin-uous renal replacement therapy (CRRT). However, the optimal post-filter ionized calcium (iCa) target level re-mains unclear. This study aims to assess the effect of increasing the post-filter iCa target level from 0.25-0.35 mmol/L to 0.30-0.40 mmol/L on filter lifespan until clotting during RCA-CRRT.Methods: This before-and-after single-center study included patients who underwent RCA-CRRT sessions without systemic anticoagulation during two periods. The first period included patients with a post-filter iCa target between 0.25 and 0.35 mmol/L, while the second period included those with a target between 0.30 and 0.40 mmol/L. The primary outcome was filter lifespan until clotting.Results: A total of 1037 CRRT sessions were analyzed, with 610 sessions in the first period and 427 sessions in the second period. After adjusting for confounding factors, there was no significant difference in filter lifespan until clotting between the two groups (hazard ratio, 1.020 [0.703; 1.481]; p = 0.92).Conclusion: Increasing the post-filter iCa target level from 0.25-0.35 mmol/L to 0.30-0.40 mmol/L during RCA-CRRT does not reduce filter lifespan until clotting and may decrease unnecessary citrate exposure. However, the optimal post-filter iCa target should be individualized according to the patient's clinical and biological status.
引用
收藏
页数:7
相关论文
共 25 条
[1]   Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs [J].
Bai, Ming ;
Zhou, Meilan ;
He, Lijie ;
Ma, Feng ;
Li, Yangping ;
Yu, Yan ;
Wang, Pengbo ;
Li, Li ;
Jing, Rui ;
Zhao, Lijuan ;
Sun, Shiren .
INTENSIVE CARE MEDICINE, 2015, 41 (12) :2098-2110
[2]   Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation [J].
Calatzis, A ;
Toepfer, M ;
Schramm, W ;
Spannagl, M ;
Schiffl, H .
NEPHRON, 2001, 89 (02) :233-236
[3]   Foreword [J].
Eckardt, Kai-Uwe ;
Kasiske, Bertram L. .
KIDNEY INTERNATIONAL SUPPLEMENTS, 2012, 2 (01) :7-7
[4]  
Fealy N, 2002, Crit Care Resusc, V4, P266
[5]   A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults [J].
Gattas, David J. ;
Rajbhandari, Dorrilyn ;
Bradford, Celia ;
Buhr, Heidi ;
Lo, Serigne ;
Bellomo, Rinaldo .
CRITICAL CARE MEDICINE, 2015, 43 (08) :1622-1629
[6]   Dose-response relationship between plasma ionized calcium concentration and thrombelastography [J].
James, MFM ;
Roche, AM .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (05) :581-586
[7]   Clinical review: Patency of the circuit in continuous renal replacement therapy [J].
Joannidis, Michael ;
Straaten, Heleen M. Oudemans-Van .
CRITICAL CARE, 2007, 11 (04)
[8]   Intensive monitoring of post filter ionized calcium concentrations during CVVHD with regional citrate anticoagulation: A retrospective study [J].
Khadzhynov, Dmytro ;
Deissler, Jonas ;
Bobonov, Otajon ;
Schelter, Christin ;
Peters, Harm ;
Kindgen-Milles, Detlef ;
Budde, Klemens ;
Lehner, Lukas Johannes ;
Halleck, Fabian ;
Staeck, Oliver ;
Eckardt, Kai-Uwe ;
Slowinski, Torsten .
JOURNAL OF CRITICAL CARE, 2020, 58 :1-5
[9]   Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation [J].
Khadzhynov, Dmytro ;
Dahlinger, Annette ;
Schelter, Christin ;
Peters, Harm ;
Kindgen-Milles, Detlef ;
Budde, Klemens ;
Lehner, Lukas Johannes ;
Halleck, Fabian ;
Staeck, Oliver ;
Slowinski, Torsten .
CRITICAL CARE MEDICINE, 2017, 45 (09) :E941-E946
[10]   Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation [J].
Khadzhynov, Dmytro ;
Schelter, Christin ;
Lieker, Ina ;
Mika, Alice ;
Staeck, Oliver ;
Neumayer, Hans. -H. ;
Peters, Harm ;
Slowinski, Torsten .
JOURNAL OF CRITICAL CARE, 2014, 29 (02) :265-271